AwesomeCapital
Search This Blog
Monday, April 28, 2025
Galmed Pharmaceuticals Signs Agreement for Novel Semaglutide Formulation
Galmed Pharmaceuticals partners with Entomus to develop a sublingual semaglutide formulation.
The new formulation offers a non-invasive alternative to existing semaglutide treatments, targeting expanding markets.
https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-signs-agreement-for-novel-semaglutide-formulation
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.